刘晓罡, 杨世诚, 付乃宽, 邵独婧, & 张鹏. (2024). 达格列净对2型糖尿病患者经皮冠状动脉介入治疗术后对比剂肾病发病的影响. 中国全科医学, 27(24), 2994-2999. https://doi.org/10.12114/j.issn.1007-9572.2023.0916
Chicago Style (17th ed.) Citation刘晓罡, 杨世诚, 付乃宽, 邵独婧, and 张鹏. "达格列净对2型糖尿病患者经皮冠状动脉介入治疗术后对比剂肾病发病的影响." 中国全科医学 27, no. 24 (2024): 2994-2999. https://doi.org/10.12114/j.issn.1007-9572.2023.0916.
MLA (9th ed.) Citation刘晓罡, et al. "达格列净对2型糖尿病患者经皮冠状动脉介入治疗术后对比剂肾病发病的影响." 中国全科医学, vol. 27, no. 24, 2024, pp. 2994-2999, https://doi.org/10.12114/j.issn.1007-9572.2023.0916.
Warning: These citations may not always be 100% accurate.